Objective: To study the relationship between body mass index (BMI) and gestational age (GA) at delivery in patients with cervical insufficiency (CI) undergoing cerclage.
Introduction
Obesity is a rising health concern in the United States. Over the past decade, obesity rates among Americans have been steadily increasing. 1 Prevalence during pregnancy is thought to range from 10 to 28%. 2, 3 Past studies have demonstrated that obesity is protective against spontaneous preterm delivery. 4, 5 However, it has been shown to be a significant risk factor for indicated preterm delivery. [5] [6] [7] Recent data indicate that preterm premature rupture of membranes is significantly increased in women with a body mass index (BMI) >30 kg m À2 . 7 Cervical insufficiency (CI) is a significant cause of preterm delivery and affects approximately 1% of all pregnancies. 8 The etiology of CI is hypothesized to be a physical deficit in the strength of the cervical tissue. 9 Cervical cerclage is the standard treatment for classical CI; however, there are conflicting data regarding its efficacy. In the appropriately chosen patient, cerclage may reduce the risk for miscarriage and preterm delivery. [10] [11] [12] The relationship between obesity and cerclage efficacy has not been studied. The objective of this study was to determine whether an obese body mass index (BMI>30 kg m
À2
) is protective against preterm birth in women with a cerclage and a history of cervical insufficiency (CI).
Methods
Demographic and obstetric characteristics were gathered prospectively from January 2003 until December 2006 on all patients presenting for evaluation of cerclage placement at Alexandria Inova Hospital in Alexandria, VA, USA, and Georgetown University Hospital in Washington, DC, USA. Women with singleton gestation were included in the study if they presented with one or more prior well-characterized mid-trimester loss characteristics for cervical incompetence (prophylactic cerclage, N ¼ 87), or with a transvaginal, cervical length <2. All cerclages were placed using Mersilene band in a modified McDonald or modified Shirodkar fashion by one of four board-certified maternal-fetal medicine specialists. The main outcome variable was rate of spontaneous preterm delivery <35 weeks. Women with a normal BMI (18.5-24.9 kg m À2 ) who had a cerclage placed for the above indications were compared with women with an obese BMI (>30 kg m À2 ) undergoing cerclage for the same indications. Chi-square test was used for categorical variables, and Student's t-test for comparison of continuous data. In addition, multivariate logistic regression analysis controlling for potential confounders such as race, prior preterm delivery, parity, genital infection, smoking history, prior cervical surgery, cerclage indication (physical examination indicated vs ultrasound, and preterm delivery history vs history of midtrimeter loss), cerclage type, indication for cerclage, pre-cerclage cervical length and gestational age (GA) at cerclage placement was used to examine the effect of sequentially increasing BMI on pregnancy outcomes, with P<0.05 being considered significant for all statistical tests.
Results
A total of 168 women with singleton gestation underwent cerclage placement during the study period. After the exclusion of 25 women who fulfilled the exclusion criteria, 143 were included in the analysis, of which 59 had normal BMI (18.5-24.9 kg m À2 ), 34 had BMI between 25 and 30 kg m À2 and 50 had BMI >30 kg m À2 . Obese patients (N ¼ 50) were similar to normal-weight patients (N ¼ 59) in regard to demographic features such as maternal age, parity, prior preterm birth, genitourinary infection and prior cervical surgery (Table 1) . However, the obese patient population comprised significantly more African-American patients than the normal BMI population (P ¼ 0.001). Cerclage characteristics including cerclage type (McDonald vs Shirodkar), pre-cerclage cervical length and cerclage indication (history vs ultrasound vs physical examination indicated) were similar, although obese patients had their cerclages placed about 1 week earlier than non-obese patients (P ¼ 0.03) ( Table 2) .
Obese women were significantly more likely to deliver before 35 weeks as opposed to women with a normal BMI (44% vs 9%, odds ratio ¼ 6.9 (95% CI: 2.5, 18.5), P<0.001). The average GA at delivery between the two groups was significantly lower in the obese group (32.6±7.0 vs 37.2±3.4 weeks P<0.001). Consequently, obese women delivered significantly smaller babies than women with a normal BMI (2192±1197 vs 3067±726 g, P<0.001); their babies required more neonatal intensive care unit (ICU) admissions (34% vs 17%, odds ratio ¼ 2.5 (95% CI: 1.0, 6.8), P ¼ 0.047) and resulted in more perinatal deaths (20 weeks or greater) (22% vs 2%, odds ratio ¼ 16.4 (95% CI: 2.0, 352.7, P<0.001)).
To assess better the effect of BMI on GA at delivery, multivariate logistic regression analysis was performed on the entire population of women in the study (N ¼ 143) by controlling for potential confounders such as race, prior preterm delivery, parity, cerclage indication, cerclage type and GA of cerclage placement. The analysis confirmed a significant association between obesity and poor obstetrical outcome (for birthweight P<0.012; for GA at delivery P ¼ 0.03). For every increase in BMI unit we saw a reduction in the GA at delivery by nearly 1 day, after adjusting for all other potential predictors.
Discussion
We have found a reduction in GA of delivery associated with increased BMI in obese patients with cerclage placement for CI. Prior studies have shown that obesity is protective against spontaneous preterm birth, 4, 5 though there may be a specific relationship between obesity and early preterm premature rupture of membranes. 7 However, no studies have examined outcomes in the obese patient with CI and cerclage placement. One can hypothesize that the etiology may involve suboptimal placement of the cerclage due to difficulty of the procedure in an obese vs a nonobese patient. The literature is conflicting regarding whether vaginal surgery in general is more complicated in the obese patient. Some studies have shown no difference in operating time, length of hospitalization or blood loss between obese and nonobese patients, 12, 13 while other studies have shown that significantly more vaginal surgeries are converted to laparotomy in obese vs nonobese patients, and that the operating time and blood loss are significantly increased in the obese patient. 14, 15 In addition, the increased weight may increase pressure on the cervix. Frezza et al. measured opening abdominal pressure in patients of varying BMI by connecting a Verress needle to a pressure monitor. 16 They proved that for every 1-kg m À2 increase in BMI, there was on average a 0.07-mm Hg increase in opening pressure. Thus, the increased abdominal pressure may increase pressure on the cervix, resulting in failure of the cerclage. However, there are no specific studies addressing pressure on the cervix. The tension-free vaginal tape (TVT) procedure is arguably similar in methodology to a cerclage. Studies comparing the effectiveness of tension-free vaginal tape in morbidly obese vs nonobese patients demonstrate increased early postoperative complications, but similar long-term effectiveness. [17] [18] [19] Thus, the etiology of decreased efficacy of cerclage in obese patients is still unclear and warrants further research.
Previous studies have found an increased risk of preterm birth among women with low weight gain and underweight women. 3 We were unable to address this issue owing to the small number of patients with a BMI <18.5 kg m À2 . Another potential weakness of our study is that patients receiving history-indicated, ultrasound/history-indicated or physical examination-indicated cerclages were grouped together, as the overall population was not large enough to permit subgroup analysis. Based on the findings of the study, we would recommend close monitoring after cerclage placement in an obese patient, especially in the early third trimester, as the average GA of delivery in the obese patient group was 32.6 weeks to identify patients who would benefit from steroid administration for fetal lung maturity. Further studies with larger numbers of patients may clarify the issue.
